Long-term prophylaxis of hereditary angioedema with danazol

Long-term prophylaxis of hereditary angioedema with danazol

Bibliographic Details
Main Authors:	Yingyang Xu, Yuxiang Zhi, Lishao Guo
Format:	Article
Language:	English
Published:	Wolters Kluwer 2022-11-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000002144

Similar Items

Long-term prophylaxis of hereditary angioedema
by: Dijana Perković, et al.
Published: (2022-12-01)

Hepatocellular Carcinoma in a Noncirrhotic Liver after Long-Term Use of Danazol for Hereditary Angioedema
by: Soraya Rahal, et al.
Published: (2014-12-01)

Long-term prophylaxis for hereditary angioedema: Initial experiences with garadacimab and lanadelumab
by: Jane C.Y. Wong, MBBS, FHKCP, et al.
Published: (2023-11-01)

Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
by: Yinshi Guo, et al.
Published: (2022-11-01)

Mutation update of SERPING1 related to hereditary angioedema in the Chinese population
by: Xue Wang, et al.
Published: (2022-07-01)

Hereditary Angioedema: Novel Molecules for Treatment of Acute Attacks and Long-Term Prophylaxis
by: Bianca Covella, et al.
Published: (2024-01-01)

Health-related quality of life and its risk factors in Chinese hereditary angioedema patients
by: Shuang Liu, et al.
Published: (2019-08-01)

Altered Urinary Metabolomics in Hereditary Angioedema
by: Xue Wang, et al.
Published: (2022-11-01)

Efficacy and Safety of an Intravenous C1-Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary angioedema
by: Timothy Craig D.O., et al.
Published: (2017-03-01)

Throat microbiota alterations in patients with hereditary angioedema
by: Xue Wang, MD, et al.
Published: (2022-10-01)

The natural course of hereditary angioedema in a Chinese cohort
by: Yang Cao, et al.
Published: (2020-09-01)

Short-term Prophylaxis for Delivery in Pregnant Women with Hereditary Angioedema with Normal C1-Inhibitor
by: Caroline Guth de Freitas Batista de Moraes, et al.
Published: (2021-01-01)

Transitioning Patients From Second- to First-Line Prophylaxis in Hereditary Angioedema
by: Caroline E Cross
Published: (2024-03-01)

Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedema
by: Richard G. Gower, et al.
Published: (2021-10-01)

Hereditary angioedema
by: Helen Lesser, et al.
Published: (2021-07-01)

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
by: Werner Aberer, et al.
Published: (2017-07-01)

Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial
by: Daisuke Honda, MD, PhD, et al.
Published: (2024-03-01)

A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis
by: Joan Mendivil, et al.
Published: (2023-05-01)

Successful long-term prophylaxis of hereditary pregnancy-associated angioedema with plasma-derived C1-inhibitor concentrate: a case report
by: D. V. Demina, et al.
Published: (2021-01-01)

Hereditary angioedema in childhood
by: Young Min Ahn
Published: (2020-01-01)

The Pathophysiology of Hereditary Angioedema
by: Bruce L Zuraw, MD
Published: (2010-01-01)

Hereditary angioedema: Not an allergy
by: Sanjay Bhivgade, et al.
Published: (2012-01-01)

Hereditary angioedema may not be the only cause of abdominal pain in patients with hereditary angioedema!
by: Ozgur Kartal, et al.
Published: (2016-09-01)

Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape
by: Daniel F. Soteres, et al.
Published: (2021-11-01)

Real-Life Experience With Subcutaneous Plasma-Derived C1-Inhibitor for Long-Term Prophylaxis in Patients With Hereditary Angioedema: A Case Series
by: Andrea Zanichelli, et al.
Published: (2022-04-01)

A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable
by: Longhurst HJ, et al.
Published: (2023-03-01)

Are pediatricians familiar with hereditary angioedema?
by: Herberto José Chong-Neto, M.D., Ph.D, et al.
Published: (2023-06-01)

Innovations in Hereditary Angioedema Pathophysiology
by: Öner Özdemir
Published: (2019-12-01)

Improving the Management of Hereditary Angioedema
by: Pedro Giavina-Bianchi, et al.
Published: (2018-05-01)

Hereditary Angioedema Consensus 2010
by: Bowen Tom
Published: (2010-07-01)

The Search for Biomarkers in Hereditary Angioedema
by: Allen P. Kaplan, et al.
Published: (2017-11-01)

Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience
by: Mohamed Abuzakouk, PhD, et al.
Published: (2022-07-01)

Food as a trigger for abdominal angioedema attacks in patients with hereditary angioedema
by: Urs C. Steiner, et al.
Published: (2018-06-01)

Clinical and Laboratory Characteristics That Differentiate Hereditary Angioedema in 72 Patients with Angioedema
by: Isao Ohsawa, et al.
Published: (2014-01-01)

Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis
by: William Lumry, et al.
Published: (2023-12-01)

Anesthesia in a patient with hereditary angioedema
by: Carlos Enríquez Fernández Montoya, et al.
Published: (2022-11-01)

The Genetics of Hereditary Angioedema: A Review
by: Rosa Santacroce, et al.
Published: (2021-05-01)

An update on the genetics and pathogenesis of hereditary angioedema
by: Aaqib Zaffar Banday, et al.
Published: (2020-03-01)

Microbiota dysbiosis in hereditary angioedema patients
by: Öner Özdemir
Published: (2023-08-01)

Pathophysiology and underlying mechanisms in hereditary angioedema
by: Alberto López Lera
Published: (2021-03-01)